Skip to main content
. 2022 Apr 21;9(7):ofac215. doi: 10.1093/ofid/ofac215

Figure 2.

Figure 2.

Flow diagram depicting case ascertainment and classification in an active surveillance system for invasive mold disease (IMD)—Georgia, 2017–2019. aA full list of specimen inclusion and exclusion criteria is available in the Supplementary Data. bPotential cases of IMD were classified using the 2020 European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (MSG) consensus definitions of invasive fungal diseases and based on clinician diagnosis and patient receipt of mold-active antifungal therapy (non-MSG IMD cases; https://academic.oup.com/cid/article/71/6/1367/5645434).